You will be be redirected to the blog in a moment...
Or you can click the link below to proceed:
FDA Approves New Appetite Suppressant Belviq From Arena Pharmaceuticals
FDA Approves New Appetite Suppressant Belviq From Arena Pharmaceuticals Main Category: Obesity / Weight Loss / Fitness Article Date: 29 Jun 2012 - 13:00 PDT The weight loss and obesity issue is rapidly over taking tobacco as the number one health concern for the coming decades. According to Centers for Disease Control and Prevention, more than one-third of adults in the United States are classified as obese. With that in mind, the FDA approved a new appetite suppressant called Belviq (lorcaserin hydrochloride) from Arena Pharmaceuticals.The drug is used for weight management in those who have either high blood pressure, high cholesterol or type 2 diabetes and have a BMI (Body Mass Index) of 27 or greater. A BMI of 27 makes someone overweight, while a BMI of 30 classifies them as obese. It should be used for chronic weight management as an addition to a reduced calorie diet and exercise. Belviq, which is manufactured by the Swiss based company Arena Pharmaceuticals Gmbh., is a slightly different approach to
Want to be redirected immediately?
Register yourself at Ping.sg to get rid of this page and also to get your read counted as Pong.